A photothermal, nanoparticle-based deep brain stimulation system restored motor skills in mice with Parkinson’s-like disease ...

The completion of the funding round follows Newronika’s recent receival of an IDE from the FDA for the Parkinson’s therapy ...

DBS is a leading financial services group in Asia with a presence in 19 markets. Headquartered and listed in Singapore, DBS is in the three key Asian axes of growth: Greater China, Southeast Asia and ...

Newronika announced today that it closed a €13.6 million ($14.1 million) Series B round to support its deep brain stimulation ...

Bank reported Q4 profit rose 10 per cent to $2.62 billion, with full-year earnings up 11 per cent to record $11.4 billion. Read more at straitstimes.com.

Newronika, a global leader in advanced deep brain stimulation, is pleased to announce the successful closing of its €13.6 ...

DBS’ earnings reflect how its robust wealth-management business is helping drive profitability amid tepid lending.

SINGAPORE: DBS Group will reward all employees, excluding senior managers, with a special one-time bonus of S$1,000 each, and ...

DBS employees are getting a windfall after the bank reported a “record performance.” The Singaporean bank is paying workers a ...

DBS announced two senior appointments on 12 February, including Derrick Goh as Group COO from 1 April. Goh, also an MP for Nee Soon GRC, will oversee the Operations and Transformation Group. His new ...

The IDE clearance paves the way for Newronika to initiate a pivotal U.S. clinical trial to evaluate the safety and efficacy of its adaptive DBS system for patients with movement disorders ...